| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), AGEN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.97M | - | - | |
| Other | 200.0K | - | - | |
| Other | 100.0K | - | - | |
| Dir | 100.0K | - | - | |
| Dir | 52.0K | $358.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Armen Garo H49 | See Remarks | Buy | 500,000 | $0.65 | $324,050.00 | +396.9% | -17.6% | -73.2% | |
| Nov 15, 2023 | Wiinberg Ulf52 | Director | Buy | 25,000 | $0.76 | $19,000.00 | +25.2% | +3.0% | -81.2% | |
| Oct 16, 2023 | Agenus Inc | 10% Owner | Buy | 22,975 | $1.10 | $25,270.25 | +0.1% | -44.3% | -78.8% | |
| Oct 4, 2023 | Agenus Inc | 10% Owner | Buy | 15,001 | $1.09 | $16,379.59 | - | -20.8% | -77.4% | |
| Aug 29, 2023 | Agenus Inc | 10% Owner | Buy | 29,678 | $1.52 | $45,015.59 | +0.1% | -51.8% | -81.4% | |
| Aug 28, 2023 | Agenus Inc | 10% Owner | Buy | 183,052 | $1.54 | $281,478.13 | +0.9% | -52.2% | -79.6% | |
| May 11, 2023 | Agenus Inc | 10% Owner | Buy | 45,426 | $1.47 | $66,643.91 | +0.2% | -8.6% | -62.5% | |
| May 5, 2023 | Agenus Inc | 10% Owner | Buy | 250,362 | $1.04 | $260,189.01 | +1.2% | -7.6% | -58.4% | |
| Jan 6, 2022 | O'Day Steven J | Chief Medical Officer | Sale+OE | 38,679 | $3.06 | $118,346.14 | -38.7% | -16.0% | -21.8% | |
| Oct 19, 2021 | Agenus Inc | 10% Owner | Buy | 1,400,000 | $12.00 | $16,800,000.00 | +7.2% | -43.8% | -48.7% |